Eculizumab for the treatment of preeclampsia/HELLP syndrome.

@article{Burwick2013EculizumabFT,
  title={Eculizumab for the treatment of preeclampsia/HELLP syndrome.},
  author={Richard M Burwick and Bruce B Feinberg},
  journal={Placenta},
  year={2013},
  volume={34 2},
  pages={201-3}
}
Severe preeclampsia with hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome is a leading cause of maternal and neonatal morbidity and mortality worldwide. Occurrence at an extremely premature gestational age is most challenging as there are dichotomous imperatives: delivery as definitive therapy for maternal health vs. prolongation of pregnancy to avoid prematurity and associated morbidities. We describe a patient presenting with severe preeclampsia/HELLP syndrome at 26 weeks… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 43 extracted citations

Similar Papers

Loading similar papers…